Head and Neck Surgical Oncology Fellowship

The University of Texas MD Anderson Cancer Center

ENT / OtolaryngologyHead & neck oncologyClinical Fellowship
Destination
USA
Houston, Texas, United States

Overview

Head and neck surgical oncology fellowship offered as one-, two- or three-year programmes developing leaders in multidisciplinary head and neck cancer care with clinical, outcomes, translational or basic science research.

The programme

Training type
Clinical Fellowship
Duration
1, 2 or 3 years
Start
Institution policyMD Anderson GME appointments are a minimum of 12 months commencing 1 July or 1 August
Positions
Not stated on official page
Accreditation
Joint Council for Approval of Advanced Teaching in Head and Neck Surgical Oncology (AHNS)
Department
Department of Head and Neck Surgery

Eligibility and visa

Eligibility
Completed residency in otolaryngology, general surgery or plastic surgery; foreign graduates not eligible for the Match may apply via the AHNS application
International applicants
Foreign medical graduates register for the match via the AHNS; AHNS programme listing states one 1-year position is open to international applicants outside the US/Canada
Visa support
Institution policyThe ECFMG-sponsored J-1 is the required visa for international physician trainees who need visa sponsorship at MD Anderson; visa-sponsored trainees may not moonlight
Licence requirement
Institution policyA Texas Medical Board Physician-in-Training (PIT) permit (obtained by the GME office for trainees without a full Texas licence) or a full Texas licence is required before starting

How to apply

Deadline
Not stated on official page
Application method
AHNS match registration (US/Canadian and foreign medical graduates)

Funding

Funding
Institution policyMD Anderson GME stipend levels AY 2026-27: PGY4 $78,917; PGY5 $81,776; PGY6 $84,650; PGY7 $88,204; PGY8 $91,399 (PGY2 $73,169); trainees may also be appointed without compensation when funded by an outside agency/government

Official sources

Similar programmes

More at The University of Texas MD Anderson Cancer Center